BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION
What was lobbied
17 issue areas, each in the filer's own words, with who lobbied on it and where.
Clean Air and Water (quality) CAW
Regulatory Actions on Biological Pesticides Climate Change Benefits of Biofuels Department of Defense Applications of Advanced Biofuels (Opposition to Section 526 Repeal)
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATT CARR | — |
| SARAH THORNTON CASWELL | — |
| BRENT ALAN DELMONTE | — |
| DANA MAURICE O'BRIEN | — |
Medicare/Medicaid MMM
Reimbursement for Innovative Products Medicare Part B Physician-Administered Products
| Lobbyist | Covered position, as disclosed |
|---|---|
| MELISSA BOWIE | — |
| BRENT ALAN DELMONTE | — |
| JEANNE HAGGERTY | — |
| ALYSON PUSEY | — |
| SARA RADCLIFFE | — |
| MATTHEW SCHUMAKER | — |
| LAUREL TODD | — |
| ANNA KATHERINE WEINSTEIN | — |
Science/Technology SCI
Research & Development Tax Credit Extension H.R. 3606: Jumpstart Our Business Start-ups (JOBS) Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRENT ALAN DELMONTE | — |
| ALAN EISENBERG | — |
| CHARLES H FRITTS | — |
| SHELLY MUI-LIPNIK | — |
Homeland Security HOM
Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Biodefense Research, Development and Procurement S 1855: Pandemic and All Hazards Preparedness Act Reauthorization of 2011
| Lobbyist | Covered position, as disclosed |
|---|---|
| PHYLLIS ARTHUR | — |
| MELISSA BOWIE | — |
| KELLY CAPPIO | — |
| BRENT ALAN DELMONTE | — |
| JEANNE HAGGERTY | — |
| TRACEY LATURNER | — |
| SARA RADCLIFFE | — |
| MATTHEW SCHUMAKER | — |
| ANNA KATHERINE WEINSTEIN | — |
Fuel/Gas/Oil FUE
Biorefineries Funding for Biorefineries Energy and Water Development Appropriations Act for FY 2013 Biofuels Economic Growth Impact/Potential of Advanced Biofuels Biofuels Production Tax Credit Modification for Algae-based Biofuels Department of Defense Applications of Advanced Biofuels (Opposition to Section 526 Repeal) Biofuels Production Tax Credit Extension Next Generation Incentives: Farm Bill Reauthorization Funding for Biofuels Energy and Water Development Appropriations Act for FY 2013 Renewable Fuels Standard Implementation of Energy Independence and Security Act of 2007 Regulatory Oversight EPA Rulemaking on Life-cycle Greenhouse Gas Emissions Requirements Bio-based Products USDA Bio-Preferred Program Economic Growth Impact/Potential of Advanced Bio-based Products Tax Credit Next Generation Incentives: Farm Bill Reauthorization Expansion of DOE and USDA Loan Guarantee Programs Funding for Bio-based Products Energy and Water Development Appropriations Act for FY 2013 Renewable Chemicals New Production Tax Credit/Revisions to Existing Tax Credits S.2155: Farm Security and Rural Investment Act of 2002 S.847: The Safe Chemicals Act of 2011 (TSCA Reform Proposals) Farm Bill Reauthorization: DOE Loan Guarantees S.1764: Make It in America Tax Credit Act of 2011
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATT CARR | — |
| SARAH THORNTON CASWELL | — |
| BRENT ALAN DELMONTE | — |
| CHARLES H FRITTS | — |
| TRACEY LATURNER | — |
| DANA MAURICE O'BRIEN | — |
| RINA SINGH | — |
Budget/Appropriations BUD
Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Center for Veterinary Medicine, Scientific Infrastructure) Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013 Funding for the USDA (Office of General Counsel, Biotechnology Regulatory Services, Animal Care & Veterinary Services (APHIS), Trade Activities (Office of the Secretary & Food Safety Inspection Service), Agriculture Research Service, Biofuels, Foreign Agriculture Service) Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013 Funding for Bio-based Products Energy and Water Development Appropriations Act for FY 2013 Funding for Biofuels Energy and Water Development Appropriations Act for FY 2013 Funding for Biorefineries Energy and Water Development Appropriations Act for FY 2013 Funding for Centers for Disease Control and Prevention Vaccine Programs Departments of Labor, Education, and Related Agencies Appropriations Act for FY 2013 Funding for National Institutes of Health Cures Acceleration Network National Center of Advancing Translational Science (NCATS) Departments of Labor, HHS, and Education, and Related Agencies Appropriations Act for FY 2013
| Lobbyist | Covered position, as disclosed |
|---|---|
| PHYLLIS ARTHUR | — |
| KELLY CAPPIO | — |
| MATT CARR | — |
| SARAH THORNTON CASWELL | — |
| BRENT ALAN DELMONTE | — |
| DAVID EDWARDS | — |
| ANDREW EMMETT | — |
| CATHLEEN ENRIGHT New | — |
| ELIZABETH CARTIER ESHAM | — |
| TRACEY LATURNER | — |
| DANA MAURICE O'BRIEN | — |
| SARA RADCLIFFE | — |
| MATTHEW SCHUMAKER | — |
Trade (domestic/foreign) TRD
Livestock Cloning/Product Labeling Discussions with EU on Animal Cloning World Trade Organization Special 301 Submissions Export Registrations for Products with Expired Patents U.S. Policy on International Science-Based Regulations Intellectual Property International Enforcement Compulsory Licensing Foreign Agricultural Biotechnology Laws and Regulations Low-Level Presence Foreign Government Policies, China Biotechnology Regulations Discussions with EU on Animal Cloning EU Biotechnology Bilateral Discussions European Union Low Level Presence Policy International Biotechnology Agreement Genetic Resource Patent Disclosure Requirement World Intellectual Property Organization TransPacific Partnership Data and Intellectual Property Protection for Pharmaceuticals Sanitary and Phytosanitary Issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| MELISSA BOWIE | — |
| JOSEPH DAMOND | — |
| BRENT ALAN DELMONTE | — |
| TOM DILENGE | — |
| DAVID EDWARDS | — |
| CATHLEEN ENRIGHT New | — |
| LILA FEISEE | — |
| CHARLES H FRITTS | — |
| JEANNE HAGGERTY | — |
| DANA MAURICE O'BRIEN | — |
| MATTHEW O'MARA | — |
| MATTHEW SCHUMAKER | — |
| ANNA KATHERINE WEINSTEIN | — |
| ROY STANFORD ZWAHLEN | — |
Agriculture AGR
TransPacific Partnership Sanitary and Phytosanitary Issues USDA/APHIS Agricultural Biotechnology Regulations Efficient Science-Based Review of Biotech Products National Environmental Policy Act Requirements Coexistence of Production Systems Biomass Crop Assistance Program (BCAP) Farm Bill Reauthorization EPA Regulations on Agricultural Biotechnology EPA Notice on PIP Data Requirements Reauthorization and Implementation of Pesticide Registration Improvement Act Departments of the Interior, Environment, and Related Agencies Appropriations Act for FY 2013 Biotechnology Stewardship Livestock Cloning/Product Labeling Discussions with EU on Animal Cloning Genetically Engineered (GE) Animals Labeling FDA Approval Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013 Amendment to Restrict FDA Approval of GE Salmon Export Registrations for Products with Expired Patents Labeling of Genetically Engineered Crops U.S. Government Policy Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013 U.S. Policy on International Science-Based Regulations Adventitious Presence (Low Level Presence) U.S. Low Level Presence Policy Foreign Agricultural Biotechnology Laws and Regulations Low-Level Presence Foreign Government Policies Discussions with EU on Animal Cloning EU Biotechnology Bilateral Discussions China Biotechnology Regulations European Union Low Level Presence Policy International Biotechnology Agreement Regulatory Actions on Biological Pesticides Agricultural Biotechnology Regulatory Reform and Modernization Benefits of Ag-Biotech Research and Innovation Funding for the USDA (Office of General Counsel, Biotechnology Regulatory Services, Animal Care & Veterinary Services (APHIS), Trade Activities (Office of the Secretary & Food Safety Inspection Service), Agriculture Research Service, Biofuels, Foreign Agriculture Service) Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRENT ALAN DELMONTE | — |
| DAVID EDWARDS | — |
| CATHLEEN ENRIGHT New | — |
| TRACEY LATURNER | — |
| DANA MAURICE O'BRIEN | — |
| MATTHEW O'MARA | — |
Taxation/Internal Revenue Code TAX
Vaccine Access/Financing Tax for Seasonal Influenza Funding Bio-based Products Tax Credit Therapeutic Discovery Project Tax Credit Extension Biofuels Biofuels Production Tax Credit Modification for Algae-based Biofuels Biofuels Production Tax Credit Extension Research & Development Tax Credit Extension H.R. 3606: Jumpstart Our Business Start-ups (JOBS) Act Capital Formation Investment Incentives Renewable Chemicals New Production Tax Credit/Revisions to Existing Tax Credits
| Lobbyist | Covered position, as disclosed |
|---|---|
| PHYLLIS ARTHUR | — |
| KELLY CAPPIO | — |
| MATT CARR | — |
| SARAH THORNTON CASWELL | — |
| CHARLES CRAIN New | — |
| BRENT ALAN DELMONTE | — |
| ALAN EISENBERG | — |
| CHARLES H FRITTS | — |
| SHELLY MUI-LIPNIK | — |
| DANA MAURICE O'BRIEN | — |
| RINA SINGH | — |
| TOOSHAR SWAIN | — |
Copyright/Patent/Trademark CPT
Patent Reform Implementation of H.R. 1249: The America Invents Act of 2011 World Trade Organization Special 301 Submissions Genetic Resource Patent Disclosure Requirement World Intellectual Property Organization Intellectual Property International Enforcement Compulsory Licensing International IP Patent Law Harmonization TransPacific Partnership Data and Intellectual Property Protections for Pharmaceuticals
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH DAMOND | — |
| BRENT ALAN DELMONTE | — |
| TOM DILENGE | — |
| LILA FEISEE | — |
| CHARLES H FRITTS | — |
| HANSJORG SAUER | — |
| ROY STANFORD ZWAHLEN | — |
Health Issues HCR
Biosimilars Biosimilars User Fee Act of 2012 (Discussion Draft) Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Funding for National Institutes of Health Cures Acceleration Network National Center of Advancing Translational Science (NCATS) Departments of Labor, HHS, and Education, and Related Agencies Appropriations Act for FY 2013 Funding for Centers for Disease Control and Prevention Vaccine Programs Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Vaccine Access/Financing Adult Immunization Policies Tax for Seasonal Influenza Funding 340B Drug Pricing Program HRSA Implementation of Program Changes Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Therapeutic Discovery Project Tax Credit Extension Rare Pediatric & Tropical Disease Drug Development Drug Safety and Review/Prescription Drug User Fee Act (PDUFA) Reauthorization Critical Path Initiative E-Pedigree and Anti-Counterfeiting Regulatory Reforms for Innovative Products Supply Chain Integrity Conflicts of Interest FDA Mission Drug Shortages Expedited Approval Pathways Access to External Experts Senate HELP Committee Discussion Draft House Energy and Commerce Committee Discussion Draft FDA Globalization Act (Discussion Draft) H.R. 2245: Preserving Access to Life Saving Medicines Act of 2011 S. 296: Preserving Access to Life-Savings Medicines Act of 2011 S. 2113: Transforming the Regulatory Environment to Accelerate Access to Treatments (TREAT) Act of 2011 H.R.3214: Food and Drug Administration Mission Reform Act of 2011 H.R.4132: Faster Access to Specialized Treatments (FAST) Act H.R.3206: Cultivating Scientific Expertise to Foster Innovation for Patients Act of 2011 H.R.1483: Drug Safety Enhancement Act of 2011 H.R.2182: Generating Antibiotic Incentives Now Act of 2011 Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Center for Veterinary Medicine, Scientific Infrastructure) Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013 Independent Payment Advisory Board H.R. 5: Protecting Access to Healthcare Act of 2011 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Biodefense Research, Development and Procurement S 1855: Pandemic and All Hazards Preparedness Act (PAHPA) Reauthorization of 2011 TransPacific Partnership Data and Intellectual Property Protection for Pharmaceuticals Reimbursement for Innovative Products Medicare Part B Physician-Administered Products
| Lobbyist | Covered position, as disclosed |
|---|---|
| PHYLLIS ARTHUR | — |
| MELISSA BOWIE | — |
| KELLY CAPPIO | — |
| JOSEPH DAMOND | — |
| BRENT ALAN DELMONTE | — |
| SANDRA DENNIS | — |
| TOM DILENGE | — |
| ALAN EISENBERG | — |
| ANDREW EMMETT | — |
| ELIZABETH CARTIER ESHAM | — |
| LILA FEISEE | — |
| CHARLES H FRITTS | — |
| JEANNE HAGGERTY | — |
| TRACEY LATURNER | — |
| SHELLY MUI-LIPNIK | — |
| ALYSON PUSEY | — |
| SARA RADCLIFFE | — |
| MATTHEW SCHUMAKER | — |
| LAUREL TODD | — |
| ANNA KATHERINE WEINSTEIN | — |
| ROY STANFORD ZWAHLEN | — |
Small Business SMB
Expansion of Exemption under SEC Regulation A H.R. 3606: Jumpstart Our Business Start-ups (JOBS) Act Sarbanes Oxley Section 404 (b) H.R. 3606: Jumpstart Our Business Start-ups (JOBS) Act S.1933: Reopening American Capital Markets to Emerging Growth Companies Act of 2011 H.R. 3213: Small Company Job Growth and Regulatory Relief Act of 2011 Small Business Early-Stage Investment H.R. 3606: Jumpstart Our Business Start-ups (JOBS) Act Therapeutic Discovery Project Tax Credit Extension Capital Formation Investment Incentives Reform of SEC Regulation D H.R. 3606: Jumpstart Our Business Start-ups (JOBS) Act S. 1831/H.R. 2940: Access to Capital for Job Creators Act of 2011 Shareholder Reporting Threshold S. 1824/H.R. 2167: Private Company Flexibility and Growth Act of 2011
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHARLES CRAIN New | — |
| BRENT ALAN DELMONTE | — |
| TOM DILENGE | — |
| ALAN EISENBERG | — |
| ELIZABETH CARTIER ESHAM | — |
| CHARLES H FRITTS | — |
| SHELLY MUI-LIPNIK | — |
| MATTHEW SCHUMAKER | — |
| TOOSHAR SWAIN | — |
Consumer Issues/Safety/Products CSP
Livestock Cloning/Product Labeling Discussions with EU on Animal Cloning USDA/APHIS Agricultural Biotechnology Regulations Efficient Science-Based Review of Biotech Products National Environmental Policy Act Requirements Coexistence of Production Systems Genetically Engineered (GE) Animals Labeling FDA Approval Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013 Amendment to Restrict FDA Approval of GE Salmon Labeling of Genetically Engineered Crops U.S. Government Policy Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013 Drug Safety and Review/Prescription Drug User Fee Act (PDUFA) Reauthorization Critical Path Initiative E-Pedigree and Anti-Counterfeiting Regulatory Reforms for Innovative Products Supply Chain Integrity Conflicts of Interest FDA Mission Drug Shortages Expedited Approval Pathways Access to External Experts Senate HELP Committee Discussion Draft House Energy and Commerce Committee Discussion Draft FDA Globalization Act (Discussion Draft) H.R. 2245: Preserving Access to Life Saving Medicines Act of 2011 S. 296: Preserving Access to Life-Savings Medicines Act of 2011 S. 2113: Transforming the Regulatory Environment to Accelerate Access to Treatments (TREAT) Act of 2011 H.R.3214: Food and Drug Administration Mission Reform Act of 2011 H.R.4132: Faster Access to Specialized Treatments (FAST) Act H.R.3206: Cultivating Scientific Expertise to Foster Innovation for Patients Act of 2011 H.R.1483: Drug Safety Enhancement Act of 2011 H.R.2182: Generating Antibiotic Incentives Now Act of 2011 Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Center for Veterinary Medicine, Scientific Infrastructure) Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013
| Lobbyist | Covered position, as disclosed |
|---|---|
| MELISSA BOWIE | — |
| BRENT ALAN DELMONTE | — |
| SANDRA DENNIS | — |
| TOM DILENGE | — |
| DAVID EDWARDS | — |
| ANDREW EMMETT | — |
| CATHLEEN ENRIGHT New | — |
| ELIZABETH CARTIER ESHAM | — |
| JEANNE HAGGERTY | — |
| TRACEY LATURNER | — |
| DANA MAURICE O'BRIEN | — |
| MATTHEW O'MARA | — |
| ALYSON PUSEY | — |
| SARA RADCLIFFE | — |
| MATTHEW SCHUMAKER | — |
| ANNA KATHERINE WEINSTEIN | — |
Energy/Nuclear ENG
Biorefineries Funding for Biorefineries Energy and Water Development Appropriations Act for FY 2013 Biofuels Economic Growth Impact/Potential of Advanced Biofuels Biofuels Production Tax Credit Modification for Algae-based Biofuels Department of Defense Applications of Advanced Biofuels (Opposition to Section 526 Repeal) Biofuels Production Tax Credit Extension Next Generation Incentives: Farm Bill Reauthorization Funding for Biofuels Energy and Water Development Appropriations Act for FY 2013 Renewable Fuels Standard Implementation of Energy Independence and Security Act of 2007 Regulatory Oversight EPA Rulemaking on Life-cycle Greenhouse Gas Emissions Requirements Bio-based Products USDA Bio-Preferred Program Economic Growth Impact/Potential of Advanced Bio-based Products Tax Credit Next Generation Incentives: Farm Bill Reauthorization Expansion of DOE and USDA Loan Guarantee Programs Funding for Bio-based Products Energy and Water Development Appropriations Act for FY 2013 Renewable Chemicals New Production Tax Credit/Revisions to Existing Tax Credits S.2155: Farm Security and Rural Investment Act of 2002 S.847: The Safe Chemicals Act of 2011 (TSCA Reform Proposals) Farm Bill Reauthorization: DOE Loan Guarantees S.1764: Make It in America Tax Credit Act of 2011
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATT CARR | — |
| SARAH THORNTON CASWELL | — |
| BRENT ALAN DELMONTE | — |
| CHARLES H FRITTS | — |
| TRACEY LATURNER | — |
| DANA MAURICE O'BRIEN | — |
| RINA SINGH | — |
Food Industry (safety, labeling, etc.) FOO
Livestock Cloning/Product Labeling Discussions with EU on Animal Cloning Genetically Engineered (GE) Animals Labeling FDA Approval Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013 Amendment to Restrict FDA Approval of GE Salmon Labeling of Genetically Engineered Crops U.S. Government Policy Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRENT ALAN DELMONTE | — |
| DAVID EDWARDS | — |
| CATHLEEN ENRIGHT New | — |
| TRACEY LATURNER | — |
| DANA MAURICE O'BRIEN | — |
Animals ANI
Livestock Cloning/Product Labeling Discussions with EU on Animal Cloning Genetically Engineered (GE) Animals Labeling FDA Approval Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013 Amendment to Restrict FDA Approval of GE Salmon
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRENT ALAN DELMONTE | — |
| DAVID EDWARDS | — |
| CATHLEEN ENRIGHT New | — |
| TRACEY LATURNER | — |
| DANA MAURICE O'BRIEN | — |
Medical/Disease Research/Clinical Labs MED
Biodefense Research, Development and Procurement S 1855: Pandemic and All Hazards Preparedness Act Reauthorization of 2011 Funding for National Institutes of Health Cures Acceleration Network National Center of Advancing Translational Science (NCATS) Departments of Labor, HHS, and Education, and Related Agencies Appropriations Act for FY 2013 Rare Pediatric & Tropical Disease Drug Development Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013
| Lobbyist | Covered position, as disclosed |
|---|---|
| PHYLLIS ARTHUR | — |
| MELISSA BOWIE | — |
| KELLY CAPPIO | — |
| BRENT ALAN DELMONTE | — |
| ELIZABETH CARTIER ESHAM | — |
| JEANNE HAGGERTY | — |
| TRACEY LATURNER | — |
| SARA RADCLIFFE | — |
| MATTHEW SCHUMAKER | — |
| ANNA KATHERINE WEINSTEIN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.